Correspondence to Dr Tom Marshall, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK; t.p.marshall{at}bham.ac.uk Objective Atrial fibrillation (AF) is the most ...

Correspondence to Dr Klaus K Witte, Division of Cardiovascular and Diabetes Research, University of Leeds, Leeds LS16 5AR, UK; k.k.witte{at}leeds.ac.uk ...

2 The School of Health and Related Research (ScHARR), The University of Sheffield, Sheffield, UK 3 The South Yorkshire Cardiothoracic Centre, Northern General Hospital, Sheffield, UK Correspondence to ...

Revascularisation of multivessel coronary artery disease (MVD) can be accomplished by either percutaneous coronary ...

Background Statistical shape atlases have been used in large-cohort studies to investigate relationships between heart shape and risk factors. The generalisability of these relationships between ...

Despite significant progress in cardiovascular pharmacotherapy and interventional strategies, cardiovascular disease (CVD) remains the leading cause of morbidity and mortality among females in the UK ...

Spontaneous coronary artery dissection (SCAD) has emerged over the last decade as an increasingly recognised cause of ...

Background Anticoagulation therapy reduces stroke risk in patients with atrial fibrillation (AF), but it is often underused in older populations due to concerns about bleeding. This study aimed to ...

Background Patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension (PAH/CTEPH) may experience physiological stress at high altitude. We investigated pulmonary ...

Background Patients with heart failure with reduced ejection fraction (HFrEF) and atrial fibrillation are mostly elderly patients, and persistent atrial fibrillation (PerAF) with multiple ...

Objective Trimethylamine-N-oxide (TMAO) is a metabolite derived from the microbial processing of dietary phosphatidylcholine and carnitine and the subsequent hepatic oxidation. Due to its ...

Correspondence to Dr Carl J Lavie, Cardiology, John Ochsner Heart and Vascular Institute, New Orleans, LA 70121, USA; clavie{at}ochsner.org In their Heart paper, O'Keeffe and colleagues4 use data from ...